References
- LawryMBiological therapy and nail psoriasisDermatol Ther200720606717403261
- FarberEMNallLNail psoriasisCutis1992501741781526170
- Van LabordeSScherRKDevelopments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis. A review of the literatureDermatol Clin200018374610626110
- AugustinMKrügerKRadtkeMASchwipplIReichKDisease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in GermanyDermatology200821636637218319601
- LeungYYTamLSKunEWLiEKPsoriatic arthritis as a distinct disease entityJ Postgrad Med200753637117244977
- WilliamsonLDalbethNDockertyJLGeeBCWeatherallRWordsworthBPExtended report: nail disease in psoriatic arthritis – clinically important, potentially treatable and often overlookedRheumatology20044379079415113998
- ReichKKrügerKMössnerRAugustinMEpidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasisBr J Dermatol20091601040104719210498
- JiaravuthisanMMSassevilleDVenderRBMurphyFMuhnCYPsoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapyJ Am Acad Dermatol20075712717572277
- BaranRThe burden of nail psoriasis. An introductionDermatology20102211520733309
- GuptaAKLyndeCWJainHCSibbaldRGElewskiBEDanielCR3rdWatteelGNSummerbellRCA higher prevalence of onychomycosis in psoriatics compaired with non-psoriatics: a multicentre studyBr J Dermatol19971367867899205520
- de JongEMSeegersBAGulinckMKBoezemanJBvan de KerkhofPCPsoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patientsDermatology19961933003038993953
- AugustinMOgilvieAMethods of outcomes measurement in nail psoriasisDermatology2010221_2328
- WilsonFCIcenMCrowsonCSMcEvoyMTGabrielSEKremersHMIncidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based studyArthritis Rheum20096123323919177544
- GuptaAKCooperEAPsoriatic nail disease: quality of life and treatmentJ Cutan Med Surg200913S102S10619799826
- KruegerGKooJLebwohlMMenterASternRSRolstadTThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyArch Dermatol200113728028411255325
- De ArrudaLHDe MoraesAPThe impact of psoriasis on quality of lifeBr J Dermatol2001144Suppl 58333611501512
- ZachariaeRZachariaeHBlomqvistKDavidssonSMolinLMørkCSigurgeirssonBQuality of life in 6497 Nordic patients with psoriasisBr J Dermatol20021461006101612072069
- ChanBHalesBShearNHoVLyndeCPoulinYMittmannNWork-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasisJ Cutan Med Surg20091319219719706226
- FowlerJFDuhMSRovbaLButeauSPinheiroLLoboFSungJDoyleJJSwensenAMallettDAKosickiGThe impact of psoriasis on health care costs and patient work lossJ Am Acad Dermatol20085977278019119095
- SohnSSchoeffskiOPrinzJReichKSchubertEWaldorfKAugustinMCost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness studyDermatology200621213714416484820
- BergerKEhlkenBKuglandBAugustinMCost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in GermanyJ Dtsch Dermatol Ges2005351151815967010
- YuAPTangJXieJWuEQGuptaSRBaoYMulaniPMEconomic burden of psoriasis compared to the general population and stratified by disease severityCurr Med Res Opin2009252429243819663687
- FeldmanSRFleischerABJrReboussinDMRappSRBradhamDDExumMLClarkARThe economic impact of psoriasis increases with psoriasis severityJ Am Acad Dermatol1997375645699344194
- KacarNErginSErdoganBSThe comparison of nail psoriasis severity index with a less time-consuming qualitative systemJ Eur Acad Dermatol Venereol20082221922218211416
- TostiAPiracciniBMCameliNKokelyFPlozzerCCannataGEBenelliCCalcipotriol ointment in nail psoriasis: a controlled double blind comparison with bethametasone dipropionate and salicylic acidBr J Dermatol19981396556599892909
- WozelGPsoriasis treatment in difficult locations: scalp, nails, and intertriginous areasClin Dermatol20082644845918755363
- RichPGriffithsCEReichKNestleFOScherRKLiSXuSHsuMCGuzzoCBaseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 yearJ Am Acad Dermatol20085822423118083272
- NoilesKVenderRNail psoriasis and biologicsJ Cutan Med Surg2009131519298765
- LugerTABarkerJLambertJYangSRobertsonDFoehlJMoltaCTBoggsRSustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasisJ Eur Acad Dermatol Venereol20092389690419453794
- ReichKApproach to managing patients with nail psoriasisJ Eur Acad Dermatol Venereol200923Suppl 1152119686381
- AugustinMKrügerKRadtkeMASchwipplIReichKDisease severity, quality of life and health care in plaque-type psoriasis: a multicenter prospective cross-sectional study in GermanyDermatology200821636637218319601
- AugustinMReichKBlomeCSchäferILaassARadtkeMANail psoriasis in Germany – epidemiology, clinical characteristics and burden of diseaseBr J Dermatol201016358058520456340
- AugustinMReichKReichCPurwinsSRustenbachSJSchaeferIRadtkeMAQuality of psoriasis care in Germany – results of the national study PsoHealth 2007J Dtsch Dermatol Ges2008664064518801145
- AugustinMReichKGlaeskeGSchaeferIRadtkeMComorbidity and age-related prevalence of psoriasis – analysis of health insurance data from more than 1.3 million persons in GermanyActa Derm Venereol20109014715120169297
- OrtonneJPBaranRCorvestMSchmittCVoisardJJTaiebCDevelopment and validation of nail psoriasis quality of life scale (NPQ10)J Eur Acad Dermatol Venereol20101241222720050290